In the last years, Ramiro has focused on the antibody immune response in atherosclerosis and has found a new atherosclerosis-associated antigen that is a target for atheroprotective antibodies (Nature 2021) and that antibodies mediate atheroprotection upon MDA-LDL immunization (Cell Reports 2022).

Ramiro was awarded a Ramón y Cajal position in 2004. She received an ERC Starting Grant (2007) and a Proof of Concept ERC Grant (2015) and grants from Health Research Grant from La Caixa Foundation in 2018 and 2022. She received the 2006 Biogen Idec Award for Young Investigators, the Banc Sabadell Award to Biomedical Research in 2013 and the Caja Rural de Granada Health Sciences Award in 2021. She was elected member of the Academia Europaea in 2022.